Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

		Phase:		Phase 2

		Treatment ID#:		1643

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		06/26/2006

		Tumor Types:		Glioblastoma Multiforme


		Comments:		RATIONALE: Drugs used in chemotherapy, such as vorinostat, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Vorinostat may also stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving vorinostat before surgery may shrink the tumor so it can be removed. Giving it after surgery may kill any remaining tumor cells.

		Treatment Type:		Chemotherapy Less-Toxics

		Contact:		Edward J. Wos DO Bismarck Cancer Center Bismarck, ND 58501 USA Phone: 701-323-5741 Fax: E-mail: Website:

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By